CSPHP From Kyowa Hakko Kogyo Receives GRAS Approval

March 6, 2004

CSPHP soy protein/phospholipid complex system may help maintain healthy cholesterol levels

New York, N.Y. – Kyowa Hakko Kogyo, and its US subsidiary, Kyowa Hakko U.S.A., have announced the Food and Drug Administration (FDA) considers CSPHP, a soy protein/phospholipid complex system that may help maintain healthy cholesterol levels within the normal range, as Generally Recognized As Safe (GRAS). CSPHP, an abbreviation for C-fraction soy protein hydrolysate with bound phospholipids, is a newly developed soy peptide.

A recent study by Kyowa Hakko Kogyo at Gifu University and Tokushima University in Japan, suggested that CSPHP helps promote healthy cholesterol levels within the normal range.

According to Yoichiro Sugimura, Kyowa Hakko Kogyo International marketing manager, beverage products in Japan with formulations that include CSPHP, have been approved by Japan’s Ministry of Health, Labor and Welfare as a Food for Specified Health Use (FOSHU).

CSPHP can be provided in tablet form or used as an ingredient in baked goods and baking mixes, breakfast cereals, diary product analogs, fats and oils, grain products and pastas, functional food and beverages, meat products, milk products, plant protein products, processed fruits and fruit juices, processed vegetables and vegetables juices and soups and soup mixes.